Consistent with the finding that SOX9 expression in the tumor was a good indicator of tumor recurrence, the serum OPN, but not AFP or PIVKA-II, level showed a significant correlation with the RFS in our analyses (Fig. 6F). The gene discussed is SPP1; the disease is neoplasm.